BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26308328)

  • 1. Effects of Narrow Band Ultraviolet B on Serum Levels of Vascular Endothelial Growth Factor and Interleukin-8 in Patients with Psoriasis.
    Chen HQ; Li X; Tang R
    Am J Ther; 2016; 23(3):e655-62. PubMed ID: 26308328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
    Akman A; Dicle O; Yilmaz F; Coskun M; Yilmaz E
    Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):123-7. PubMed ID: 18477130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Br J Dermatol; 2010 Dec; 163(6):1282-90. PubMed ID: 20716219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Galectin3 levels in psoriatic patients treated by narrow-band UVB phototherapy.
    Khater MH; AbdallaAlhabib S; Elkshishy KA; Khattab FM
    J Dermatolog Treat; 2020 Dec; 31(8):758-762. PubMed ID: 31557066
    [No Abstract]   [Full Text] [Related]  

  • 5. Systematic review of UV-based therapy for psoriasis.
    Almutawa F; Alnomair N; Wang Y; Hamzavi I; Lim HW
    Am J Clin Dermatol; 2013 Apr; 14(2):87-109. PubMed ID: 23572293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis.
    Rácz E; de Leeuw J; Baerveldt EM; Kant M; Neumann HA; van der Fits L; Prens EP
    Lasers Surg Med; 2010 Mar; 42(3):201-10. PubMed ID: 20333742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial.
    Lynch M; Malara A; Timoney I; Vencken S; Ahern T; Awdeh F; Sweeney C; Galligan M; Kelly G; Hughes R; Murad A; Hambly R; O'Shea D; Doran P; Kirby B
    Dermatology; 2022; 238(1):140-147. PubMed ID: 33866313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients.
    Narbutt J; Olejniczak I; Sobolewska-Sztychny D; Sysa-Jedrzejowska A; Słowik-Kwiatkowska I; Hawro T; Lesiak A
    Arch Dermatol Res; 2013 Apr; 305(3):191-5. PubMed ID: 23108364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment.
    Erek Toprak A; Ozlu E; Uzuncakmak TK; Yalcınkaya E; Sogut S; Karadag AS
    Med Sci Monit; 2016 Apr; 22():1232-7. PubMed ID: 27070789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis.
    Rui W; Xiangyu D; Fang X; Long G; Yi Y; Wenjuan W; Tian H; Xiaoning Z; Yong Z; Jianfeng F; Hengjin L; Chengxin L
    Medicine (Baltimore); 2017 Dec; 96(50):e8677. PubMed ID: 29390261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.
    Lynch M; Ahern TB; Timoney I; Sweeney C; Kelly G; Hughes R; Tobin AM; O'Shea D; Kirby B
    Trials; 2016 Jan; 17():29. PubMed ID: 26767505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL17A and IL17F Gene Polymorphism Association with Psoriasis Risk and Response to Treatment in a Polish Population.
    Białecka M; Ostasz R; Kurzawski M; Klimowicz A; Fabiańczyk H; Bojko P; Dziedziejko V; Safranow K; Machoy-Mokrzyńska A; Droździk M
    Dermatology; 2016; 232(5):592-596. PubMed ID: 27591988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrow-band ultraviolet B radiation: a review of the current literature.
    Bandow GD; Koo JY
    Int J Dermatol; 2004 Aug; 43(8):555-61. PubMed ID: 15304175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy.
    Abu El-Hamd M; Adam El Taieb M; Mahmoud AA; Mahmoud Samy O
    J Dermatolog Treat; 2019 Sep; 30(6):545-548. PubMed ID: 30482111
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
    Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
    J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate, but not narrowband ultraviolet B radiation, suppresses interleukin-33 mRNA levels in psoriatic plaques and protein levels in serum of patients with psoriasis.
    Meephansan J; Subpayasarn U; Ponnikorn S; Chakkavittumrong P; Juntongjin P; Komine M; Ohtsuki M; Poovorawan Y
    J Dermatol; 2018 Mar; 45(3):322-325. PubMed ID: 28836690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-22 and vascular endothelial growth factor serve as sensitive biomarkers but not as predictors of therapeutic response to biologics in patients with psoriasis.
    Shimauchi T; Hirakawa S; Suzuki T; Yasuma A; Majima Y; Tatsuno K; Yagi H; Ito T; Tokura Y
    J Dermatol; 2013 Oct; 40(10):805-12. PubMed ID: 23915382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
    Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum YKL-40 and IL 17 in Psoriasis: Reliability as prognostic markers for disease severity and responsiveness to treatment.
    Khashaba SA; Attwa E; Said N; Ahmed S; Khattab F
    Dermatol Ther; 2021 Jan; 34(1):e14606. PubMed ID: 33249724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.